Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian C Schrader

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Medical Microbiology : IJMM|August 18, 2012
The antimalarial pipeline--an updateFlorian C Schrader, Marlene Barho, Iljana Steiner, et al.
Chemmedchem|July 22, 2014
N-acyl derivatives of 4-phenoxyaniline as neuroprotective agentsMarlene T Barho, Sina Oppermann, Florian C Schrader, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2014
Novel N-phenyl-substituted thiazolidinediones protect neural cells against glutamate- and tBid-induced toxicitySina Oppermann, Florian C Schrader, Katharina Elsässer, et al.
Chemmedchem|January 24, 2013
Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agentsFlorian C Schrader, Serghei Glinca, Julia M Sattler, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Medical Microbiology : IJMM|August 18, 2012
The antimalarial pipeline--an updateFlorian C Schrader, Marlene Barho, Iljana Steiner, et al.
Chemmedchem|July 22, 2014
N-acyl derivatives of 4-phenoxyaniline as neuroprotective agentsMarlene T Barho, Sina Oppermann, Florian C Schrader, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2014
Novel N-phenyl-substituted thiazolidinediones protect neural cells against glutamate- and tBid-induced toxicitySina Oppermann, Florian C Schrader, Katharina Elsässer, et al.
Chemmedchem|January 24, 2013
Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agentsFlorian C Schrader, Serghei Glinca, Julia M Sattler, et al.
Pageof 1